Portland, OR -- (SBWire) -- 07/07/2017 --Plasma fractionation is a process of separating various components of plasma. It is used in in prevention and treatment of life threatening diseases caused by trauma, immunologic disorders, and infections. Plasma fractionation process is used in treating protein deficiency in healthcare applications. It is also used in production of packaging material for industrial applications. The removal or inactivation of viruses and prions is a prime function of plasma fractionation.

Early buyers will receive 20% customization on this report

The world plasma fractionation market is segmented based on product, application, end user, and geography. On the basis of products, the market is classified into albumin, immunoglobulins, coagulation factor concentrates, and others. The immunoglobulin segment is further classified into subcutaneous immunoglobulin (SCIg), intravenous immunoglobulin (IVIg), and others. Coagulation factor concentrates are divided into factor VIII, factor IX, factor XIII, Von Willebrand factor, prothrombin coagulation concentrates, and fibrinogen concentrates. Applications included in the report are neurology, hematology, immunology, critical care, and others. End users covered in the report are hospitals and clinical research laboratories. Geographically, the market is divided into North America, Europe, Asia-Pacific, and Latin America, Middle East and Africa (LAMEA).

Get full summary of the Report: https://www.alliedmarketresearch.com/plasma-fractionation-market

The prominent companies operating in the market are Grifols SA, Baxter International Inc., CSL Ltd., Bio Product Laboratory, Octapharma AG, Sanquin, Laboratoire Franais du Fractionnement et des Biotechnologies, Kedrion, and Biotest. Partnerships, collaborations, mergers & acquisitions, agreements, expansions, joint ventures, and others are some of the key strategies adopted by these prominent manufacturers to strengthen their position in the market.

Request Sample Report: https://www.alliedmarketresearch.com/request-toc-and-sample/943

KEY MARKET SEGMENTS
The Plasma Fractionation Market By Product
- Albumin
- Immunoglobulins
- Subcutaneous Immunoglobulin (SCIg)
- Intravenous Immunoglobulin (IVIg)
- Others

Coagulation Factor Concentrates
- Factor VIII
- Factor IX
- Factor XIII
- Von Willebrand Factor
- Prothrombin Coagulation Concentrates
- Fibrinogen Concentrates
- Others

The Plasma Fractionation Market By Application
- Neurology
- Hematology
- Immunology
- Critical Care
- Others

The Plasma Fractionation Market By End User
- Hospitals
- Clinical Research Laboratories
- The Plasma Fractionation Market By Geography
- North America
- Asia-Pacific
- Europe
- Latin America, Middle East and Africa (LAMEA)

Key Market Players
- Grifols SA
- Baxter International Inc.
- CSL Ltd.
- Bio Product Laboratory
- Octapharma AG
- Sanquin
- Laboratoire Franais du Fractionnement et des Biotechnologies
- Kedrion
- Biotest